STAT
statnews.comSTAT is a U.S.-based digital news outlet focused on health, medicine, life sciences, and biotechnology. It publishes reporting, analysis, investigations, and commentary for both general readers and professionals in the health and biotech sectors.
- Credibility
- 4 of 5
- Lean
- Center
- Founded
- 2015
- Headquarters
- Boston
- United States
- Articles read
- 8,315
- 20 February 2018 to 3 November
In today’s Brief
Tuesday 3 NovemberNot in today’s Brief.
Recent
Fetched 3 November, 11:27 UTCTuesday 3 November
- Mortality rate was 19.2% higher in Trump-voting states than Harris-voting states in 2024.
- Meditation helped me become a better doctor overnight
- Three-parent IVF raises questions as MRT data temper optimism.
Monday 2 November
- Washington state resident dies from bird flu linked to dairy cattle
- Health care costs drive midterm voting decisions
- Psilocybin’s lasting benefits elusive in mice
- FDA approves generic lenacapavir for HIV prevention to widen access
- Four big drugmakers paid Russian intermediaries; Kymera may rival Dupixent
STAT
statnews.comSTAT is a U.S.-based digital news outlet focused on health, medicine, life sciences, and biotechnology. It publishes reporting, analysis, investigations, and commentary for both general readers and professionals in the health and biotech sectors.
- Credibility
- 4 of 5
- Lean
- Center
- Founded
- 2015
- Headquarters
- Boston
- United States
- Articles read
- 8,315
- 20 Feb 2018 to 3 Nov
In today’s Brief
Tuesday 3 NovemberNot in today’s Brief.
Recent
Fetched 3 November, 11:27 UTCTuesday 3 November
- Mortality rate was 19.2% higher in Trump-voting states than Harris-voting states in 2024.
- Meditation helped me become a better doctor overnight
- Three-parent IVF raises questions as MRT data temper optimism.
Monday 2 November
- Washington state resident dies from bird flu linked to dairy cattle
- Health care costs drive midterm voting decisions
- Psilocybin’s lasting benefits elusive in mice
- FDA approves generic lenacapavir for HIV prevention to widen access
- Four big drugmakers paid Russian intermediaries; Kymera may rival Dupixent
Profile
- Type
- Online only
- Ownership
- Owned by Boston Globe Media, which is controlled by John W. Henry.
- Funding
- Subscriptions, advertising, sponsorships, and events.
- Coverage
- STAT covers biomedical research, pharmaceuticals, biotechnology, health policy, medicine, public health, and the business of health care.
- Reputation
- It is generally regarded as a specialized and influential source for health and biotech journalism, with strengths in industry reporting and investigations, though some material is aimed at professional audiences and sits behind a paywall.
- Language
- English
- Notes
- Some articles and analysis are behind the STAT+ subscription paywall.
- It is part of Boston Globe Media rather than an independent nonprofit or academic publisher.
ProfileAI-generated summaryWritten under a strict no-guessing rule. Facts the model isn’t sure of are left out.Verify independently before citing.Fetched 3 November, 11:27 UTCRatingsAllSides and Media Bias/Fact CheckLean and credibility come from public ratings (AllSides, MBFC).Unknown outlets stay unrated.Curated v1 mapping